Cerebrovascular Reactivity: a Stress Test of Brain Vascular Health in Moyamoya Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
This scientific commentary refers to 'Cerebrovascular reactivity and response times describe recent ischemic symptomatology in patients with moyamoya', by Han . (https://doi.org/10.1093/braincomms/fcae381).
References
1.
Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T
. Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE). Stroke. 2023; 54(6):1494-1504.
DOI: 10.1161/STROKEAHA.122.041932.
View
2.
Deckers P, van Hoek W, Kronenburg A, Yaqub M, Siero J, Bhogal A
. Contralateral improvement of cerebrovascular reactivity and TIA frequency after unilateral revascularization surgery in moyamoya vasculopathy. Neuroimage Clin. 2021; 30:102684.
PMC: 8102652.
DOI: 10.1016/j.nicl.2021.102684.
View
3.
Mutch W, Mandell D, Fisher J, Mikulis D, Crawley A, Pucci O
. Approaches to brain stress testing: BOLD magnetic resonance imaging with computer-controlled delivery of carbon dioxide. PLoS One. 2012; 7(11):e47443.
PMC: 3489910.
DOI: 10.1371/journal.pone.0047443.
View
4.
Detre J, Samuels O, Alsop D, Kasner S, Raps E
. Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging. 1999; 10(5):870-5.
DOI: 10.1002/(sici)1522-2586(199911)10:5<870::aid-jmri36>3.0.co;2-d.
View
5.
Gonzalez N, Amin-Hanjani S, Bang O, Coffey C, Du R, Fierstra J
. Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke. 2023; 54(10):e465-e479.
DOI: 10.1161/STR.0000000000000443.
View